Giving people back their lives!

HBOT in PTSD

U.S. Veteran Pilot Trial LSU IRB #7051 HBOT in TBI/PTSD Preliminary Data

Preliminary Report on Hyperbaric Oxygen Treatment (HBOT) of U.S. Military Veterans with Traumatic Brain Injury (TBI) and Post-Traumatic Stress Disorder (PTSD):  The LSU IRB #7051 Pilot Trial

2011-02-14

Paul G. Harch 1, Susan R. Andrews1, Edward Fogarty2, Juliette Lucarini1, Claire Aubrey1, Paul K. Staab1, Keith W. Van Meter1 1Louisiana State University School of Medicine, United States, 2University of North Dakota School of Medicine, United States 

Dr. Paul Harch of Harch Hyperbarics Inc. Treats TBI/PTSD with HBOT for Iraq Veteran Casey Owens

Here Dr. Paul Harch, MD (HBOT.com) treats Iraq veteran Casey Owens for a traumatic brain injury and post traumatic stress disorder. Owens lost both legs and the beginning of the story recounts Casey's attempts for treatment of a non-healing wound on one of his legs. What was probably part of this original story is the ironic fact that the VA could have used HBOT for wound healing treatment to heal his leg as well as his brain, albeit by utilizing different protocols. Chronic wound healing requires pressures above 2 ATA while brain-injury repair is usually below 2 ATA, usually 1.5 ATA. This video was first broadcast on the CBS Evening News with Katie Couric on August 3, 2009.

Dr Paul Harch's Testimony HASC For The Record, FDA Approval of HBOT for Traumatic Brain Injury

TESTIMONY FOR THE RECORD: Regarding FDA approval of Hyperbaric Oxygen Therapy (HBOT) to treat traumatic brain injury (TBI), off-label prescription drug use by the Department of Defense for TBI and post-traumatic stress disorder (PTSD), and the potential relationship of this drug use to the incidence of suicides in United States Service members. The National Brain Injury Rescue and Rehabilitation Project continues to reaffirm the biological nature of blast-induced brain injuries incurred by coalition forces in Iraq and Afghanistan . Fortunately, preliminary evidence at multiple centers suggests that these TBI war casualties respond to a low pressure protocol (HBOT 1.5) of Hyperbaric Oxygen Therapy.  HBOT uses oxygen as an FDA-approved drug and is known to be a non-specific biological repair therapy for acute and chronic wounds. HBOT is the only FDA-approved treatment known to biologically repair and regenerate human tissue and activate growth factors at a DNA level. It is FDA-approved to treat conditions like blunt trauma, crush injury and non-healing wounds. Three of the 13 FDA-approved indications are for neurological injury. Physicians are permitted to use an approved drug or device “off-label” when they believe the underlying mechanisms of action may help a patient with a non-approved condition.

TBI / PTSD Treatment with Hyperbaric Oxygen Therapy for Wounded Warriors with Traumatic Brain Injury and/or Post Traumatic Stress Disorder at LSUHSC

New Orleans, LA – Dr. Paul Harch, LSUHSC Clinical Associate Professor of Emergency Medicine, is the principal investigator of a pilot study to determine the effectiveness of one or two courses of hyperbaric oxygen therapy in treating chronic traumatic brain injury (TBI) and TBI with post traumatic stress disorder (PTSD). The study grew out of previous experience in treating TBI with hyperbaric oxygen therapy with improvement in symptoms and function.

Thirty participants will be recruited – half will have traumatic brain injury and half will have both traumatic brain injury and post traumatic stress disorder. The participants will undergo oral, written, and computers tests, as well as an MRI (if the participant has not had one since injury) and SPECT brain imaging. Participants will have 40 hyperbaric oxygen therapy treatments and can request up to 40 more if not improved to his/her satisfaction.

Certain conditions preclude participation including pregnancy and increased risk for rare HBOT complications.

Pages